(Q33908544)

29 July 2017

1 reference

title

Nimodipine for primary degenerative, mixed and vascular dementia (English)

1 reference

29 July 2017

0 references

1 reference

J M López-Arrieta

1

1 reference

29 July 2017

J Birks

series ordinal

2

1 reference

29 July 2017

López-Arrieta

series ordinal

1

0 references

language of work or name

English

0 references

publication date

1 January 2000

1 reference

Cochrane Database of Systematic Reviews

29 July 2017

2002

0 references

2001

0 references

published in

1 reference

29 July 2017

CD000147

1 reference

29 July 2017

2

1 reference

Nimodipine in the treatment of old age dementias.

29 July 2017

3

0 references

1

0 references

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000147

Short-term effects of the calcium channel blocker nimodipine (Bay-e-9736) in the management of primary degenerative dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000147

The Scandinavian Multi-Infarct Dementia Trial: a double-blind, placebo-controlled trial on nimodipine in multi-infarct dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000147

Efficacy and safety of nimodipine in subcortical vascular dementia: a subgroup analysis of the Scandinavian Multi-Infarct Dementia Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000147

Efficacy and safety of nimodipine in subcortical vascular dementia: a randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000147

Pharmacokinetics of nimodipine in multimorbid elderly patients with chronic brain failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000147

A phase I/II trial of nimodipine for HIV-related neurologic complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000147

Effect of nimodipine on memory after cerebral infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000147

Bias in treatment assignment in controlled clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000147

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000147

Factor structure and scoring of the SKT test battery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000147

The assessment of self-care capacity in geriatric psychiatric patients by objective and subjective methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000147

A new rating scale for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000147

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000147

Development and validation of the geriatric evaluation by relatives rating instrument (GERRI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000147

A new scale for clinical assessment in geriatric populations: Sandoz Clinical Assessment--Geriatric (SCAG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000147

A Standardized Memory Scale for Clinical Use

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000147

10.1002/14651858.CD000147

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference